Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2012 | 3 |
2013 | 2 |
2016 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Predominantly proinflammatory cytokines decrease after B cell depletion therapy in patients with primary Sjogren's syndrome.
Ann Rheum Dis. 2013 Dec;72(12):2048-50. doi: 10.1136/annrheumdis-2013-203447. Epub 2013 Jul 17.
Ann Rheum Dis. 2013.
PMID: 23864239
Clinical Trial.
No abstract available.
Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment.
Delli K, Haacke EA, Kroese FG, Pollard RP, Ihrler S, van der Vegt B, Vissink A, Bootsma H, Spijkervet FK.
Delli K, et al. Among authors: pollard rp.
Ann Rheum Dis. 2016 Nov;75(11):1933-1938. doi: 10.1136/annrheumdis-2015-208304. Epub 2016 Jan 12.
Ann Rheum Dis. 2016.
PMID: 26757748
Clinical Trial.
Item in Clipboard
Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren's syndrome: a retrospective clinical study.
Pollard RP, Pijpe J, Bootsma H, Spijkervet FK, Kluin PM, Roodenburg JL, Kallenberg CG, Vissink A, van Imhoff GW.
Pollard RP, et al.
J Rheumatol. 2011 Oct;38(10):2198-208. doi: 10.3899/jrheum.110077. Epub 2011 Aug 15.
J Rheumatol. 2011.
PMID: 21844152
Item in Clipboard
In primary Sjögren's syndrome high absolute numbers and proportions of B cells in parotid glands predict responsiveness to rituximab as defined by ESSDAI, but not by SSRI.
Delli K, Haacke EA, Kroese FG, Pollard RP, Ihrler S, van der Vegt B, Vissink A, Bootsma H, Spijkervet FK.
Delli K, et al. Among authors: pollard rp.
Ann Rheum Dis. 2016 Jun;75(6):e34. doi: 10.1136/annrheumdis-2016-209317. Epub 2016 Mar 9.
Ann Rheum Dis. 2016.
PMID: 26961295
No abstract available.
Item in Clipboard
Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial.
Pollard RP, Abdulahad WH, Vissink A, Hamza N, Burgerhof JG, Meijer JM, Visser A, Huitema MG, Spijkervet FK, Kallenberg CG, Bootsma H, Kroese FG.
Pollard RP, et al.
Ann Rheum Dis. 2013 Jan;72(1):146-8. doi: 10.1136/annrheumdis-2012-202071. Epub 2012 Jul 31.
Ann Rheum Dis. 2013.
PMID: 22851468
Clinical Trial.
No abstract available.
Item in Clipboard
Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjögren's syndrome after B cell depletion therapy.
Hamza N, Bootsma H, Yuvaraj S, Spijkervet FK, Haacke EA, Pollard RP, Visser A, Vissink A, Kallenberg CG, Kroese FG, Bos NA.
Hamza N, et al. Among authors: pollard rp.
Ann Rheum Dis. 2012 Nov;71(11):1881-7. doi: 10.1136/annrheumdis-2011-201189. Epub 2012 May 21.
Ann Rheum Dis. 2012.
PMID: 22615459
Item in Clipboard
Systems analysis of primary Sjögren's syndrome pathogenesis in salivary glands identifies shared pathways in human and a mouse model.
Horvath S, Nazmul-Hossain AN, Pollard RP, Kroese FG, Vissink A, Kallenberg CG, Spijkervet FK, Bootsma H, Michie SA, Gorr SU, Peck AB, Cai C, Zhou H, Wong DT.
Horvath S, et al. Among authors: pollard rp.
Arthritis Res Ther. 2012 Nov 1;14(6):R238. doi: 10.1186/ar4081.
Arthritis Res Ther. 2012.
PMID: 23116360
Free PMC article.
Item in Clipboard
Cite
Cite